RNAi-mediated knockdown of α-enolase increases the sensitivity of tumor cells to antitubulin chemotherapeutics.
about
Gamma-enolase: a well-known tumour marker, with a less-known role in cancerComparative Proteomic Analysis of Advanced Ovarian Cancer Tissue to Identify Potential Biomarkers of Responders and Nonresponders to First-Line Chemotherapy of Carboplatin and Paclitaxel.Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasisα-Enolase, a multifunctional protein: its role on pathophysiological situationsRh2E2, a novel metabolic suppressor, specifically inhibits energy-based metabolism of tumor cells.Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners.
P2860
RNAi-mediated knockdown of α-enolase increases the sensitivity of tumor cells to antitubulin chemotherapeutics.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
RNAi-mediated knockdown of α-e ...... antitubulin chemotherapeutics.
@ast
RNAi-mediated knockdown of α-e ...... antitubulin chemotherapeutics.
@en
type
label
RNAi-mediated knockdown of α-e ...... antitubulin chemotherapeutics.
@ast
RNAi-mediated knockdown of α-e ...... antitubulin chemotherapeutics.
@en
prefLabel
RNAi-mediated knockdown of α-e ...... antitubulin chemotherapeutics.
@ast
RNAi-mediated knockdown of α-e ...... antitubulin chemotherapeutics.
@en
P2093
P2860
P1476
RNAi-mediated knockdown of α-e ...... antitubulin chemotherapeutics
@en
P2093
Anne-Marie Bonneau
Elias Georges
Panagiotis Prinos
P2860
P304
P577
2011-10-21T00:00:00Z